FDA-Cleared Biomarker Tests Are On The Upswing

As previously reported in this blog, review periods for biomarker-based IVD tests were shorter in 2013 for the second year in a row. This continued the reversal of a decade-long trend of increasing review periods. We can also now report that more biomarker-based tests...

Real-Time COVID R&D Tracking

As COVID-19 infections continue to spread, organizations with technologies or devices that can support new drug, vaccine, or test development have a life-saving contribution to make. The Amplion Intelligence Platform can alert you to new COVID-19 trial activities in real-time and automatically match you to partners who need your unique capabilities immediately. It’s already tomorrow somewhere, so let us help you start today.  Learn More

Request Access